Maharashtra Health Minister Rajesh Tope on Wednesday hinted at the possibility of new strains of COVID-19 in the state as "some patients are showing behaviours other than routine ones."
"New Strains are suspected because we are seeing other behaviours in COVID-19 patients than routine behaviours. Patients are also showing non-routine behaviours after the infection," Tope said.
"National Institute of Virology (NIV) is doing genomic sequencing of our samples. It is sending its report to National Centre for Disease Control (NCDC). Now, NCDC will guide us about if any new protocol is to be followed for the treatment," he added.
Informing that as the state, currently, is consuming 50,000 doses of COVID-19 drug Remdesivir on a daily basis, Maharashtra needs a higher number of doses.
The price of Remdesivir will be capped between Rs 1100-1400 per dose.
Tope was addressing a press conference over the COVID-19 situation in the state on Wednesday.
Earlier, he said that the state is facing a vaccine shortage and has requested 40 lakh doses every week from the Centre.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)